临床荟萃

• 论著 • 上一篇    下一篇

稳定期慢性阻塞性肺疾病患者非侵入性标记物研究

  

  1. 泰州市人民医院 老年科, 江苏 泰州  225300
  • 出版日期:2016-11-05 发布日期:2016-11-04
  • 通讯作者: 通信作者:鞠俊强,Email:jjqtz@sina.com
  • 基金资助:
    通信作者:鞠俊强,Email:jjqtz@sina.com

Noninvasive markers in patients with stable chronic obstructive pulmonary disease

  1. Department of Geriatrics, Taizhou People's Hospital, Taizhou 225300, China
  • Online:2016-11-05 Published:2016-11-04
  • Contact: Corresponding author: Ju Junqiang,Email:jjqtz@sina.com

摘要: 目的比较慢性阻塞性肺疾病(COPD)患者和健康受试者非侵入性标记物,评估其与吸烟的关系。方法选取在我院治疗的稳定期COPD戒烟患者52例(COPD EX组),稳定期COPD吸烟患者36例(COPD S组),在我院体检的健康的吸烟者23例(HE S组),健康的戒烟者23例(HE EX组)。比较所有受试者呼出气冷凝物(EBC)、痰液中前列腺素E2(PGE2)和异构前列腺素15F2tisoprostane(15F2tIsoP)的水平、呼出气一氧化氮(FeNO)、痰细胞计数和肺功能。结果与COPD S组比较,COPD EX组的FeNO值明显提高;与两健康组比较,两COPD组EBC中15F2tIsoP水平明显升高(P<0.05);与同等健康状况的戒烟者比较,吸烟者尿液中15F2tIsoP水平升高(P<0.05)。结论不同类型炎症性标志物的联合检测分析可用于对COPD患者呼吸炎症的综合评估。

关键词: 肺疾病, 慢性阻塞性;生物学标记;吸烟

Abstract: ObjectiveTo compare the noninvasive markers between chronic obstructive pulmonary disease (COPD) patients and healthy subjects and to assess their relationship with smoking. MethodsThe subjects included 52 COPD exsmoking patients (COPD EX group,n=52) and 36 smoking patients (COPD S group,n=36) treated in our hospital, 23 healthy exsmokers (HE EX group,n=23) and 23 healthy smokers (HE S group,n=23) medically examined in our hospital. Prostaglandin E2 (PGE2), and prostaglandin isomers 15F2tisoprostane (15F2tIsoP) concentrations in sputum, exhaled breath condensate (EBC), fraction of exhaled nitric oxide, sputum cell counts and pulmonary function test were detected and compared. ResultsCompared with COPD S group, FeNO values in COPD EX group increased significantly (P<0.01); Compared with healthy group, the EBC 15F2tIsoP concentrations in two groups with COPD increased significantly (P<0.05); Compared with smokers who had equal health status, the urine 15F2tIsoP concentration in both smokers groups increased significantly (P<0.05).ConclusionThe combination of different types of inflammatory markers can be used for a comprehensive assessment of COPD respiratory inflammation.

Key words: pulmonary disease, chronic obstructive, biological markers, smoking